Greager J A, Chao T C, Blend M J, Atcher R W, Gansow O A, Brechbiel M W, Das Gupta T K
Department of Surgery, University of Illinois College of Medicine, Chicago 60612.
J Nucl Med. 1990 Aug;31(8):1378-83.
In order to study localization of metastatic tumors with a radiolabeled monoclonal antibody, a pulmonary metastases model was devised in athymic mice. Metastatic pulmonary sarcoma colonies were verified by histological examination. A murine monoclonal antibody (MAb 19-24) directed against a human sarcoma antigen was labeled with indium-111 (111In) by use of the linker 1-(p-isothiocyanatobenzyl)-diethylenetriaminepentaacetic acid (SCN-Bz-DTPA). MAb P3 was similarly labeled as a negative control. In the group given MAb 19-24, the percent injected dose per gram lung tissue bearing tumor colonies (30.1%, 29.6%, and 27.7% on Days 1, 2, and 3, respectively) was significantly (p less than 0.05) higher than in those receiving MAb P3. Hepatic activities of both 111In-MAb 19-24 and 111In-MAb P3 were low. The lungs with tumor colonies demonstrated clearest images on Day 3. The specific binding of 111In-SCN-Bz-DTPA-labeled MAb 19-24 to pulmonary xenografts without appreciable liver uptake indicates that it may be useful in the clinical localization of pulmonic metastatic lesions.
为了用放射性标记的单克隆抗体研究转移性肿瘤的定位,在无胸腺小鼠中设计了肺转移模型。通过组织学检查证实了转移性肺肉瘤集落。使用连接剂1-(对异硫氰酸苄基)-二乙三胺五乙酸(SCN-Bz-DTPA)将针对人肉瘤抗原的鼠单克隆抗体(MAb 19-24)用铟-111(¹¹¹In)标记。MAb P3同样被标记作为阴性对照。在给予MAb 19-24的组中,每克带有肿瘤集落的肺组织的注射剂量百分比(分别在第1、2和3天为30.1%、29.6%和27.7%)显著高于接受MAb P3的组(p<0.05)。¹¹¹In-MAb 19-24和¹¹¹In-MAb P3的肝脏活性都很低。带有肿瘤集落的肺在第3天显示出最清晰的图像。¹¹¹In-SCN-Bz-DTPA标记的MAb 19-24与肺异种移植的特异性结合且肝脏摄取不明显,表明它可能对肺转移性病变的临床定位有用。